INTEGRA LIFESCIENCES HOLDINGS CORP

IART

INTEGRA LIFESCIENCES HOLDINGS CORP

IART

Insider Sentiment (TTM):

Last Purchase:2025-11-05Last Sale:2024-12-03Shares Purchased (TTM):9,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:73,646,734Shares Outstanding:76,951,000Institutional Ownership Pct.:95.71%

Earnings Market Reaction:

Filing Date:2026-07-29Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	214	237	235	232	218	239	246	215	215	592	276	274
Short Term Investments	60	29	29	36	36	34	27	62	82	71	33	-
Accounts Receivable Net Current	267	264	279	262	285	252	272	248	271	241	259	256
Inventory Net	492	495	493	489	465	445	429	437	422	403	390	366
Prepaid Expense And Other Assets Current	-	-	-	-	-	-	-	-	-	-	-	131
Prepaid Expense Current	104	98	96	94	103	104	77	86	94	73	67	-
Other Assets Current	54	49	28	30	36	32	30	50	29	35	33	-
Assets Current	1,191	1,172	1,160	1,144	1,143	1,107	1,082	1,100	1,112	1,416	1,058	1,027
Property Plant And Equipment Net	446	447	444	437	435	423	406	391	374	345	340	319
Operating Lease Right Of Use Asset	137	137	141	138	137	138	144	146	147	152	156	157
Intangible Assets Net Excluding Goodwill	1,076	1,105	1,135	1,160	1,188	1,188	1,208	1,210	1,220	1,023	1,068	1,067
Goodwill	611	613	615	615	616	1,105	1,097	1,117	1,105	1,040	1,055	1,036
Deferred Income Tax Assets Net	70	68	70	110	103	38	35	49	46	34	46	56
Other Assets Noncurrent	32	35	38	42	46	53	67	54	71	68	58	78
Assets	3,563	3,578	3,602	3,646	3,668	4,053	4,037	4,066	4,074	4,078	3,782	3,739
Liabilities And Stockhold…
Liabilities Current
Secured Debt Current	44	39	39	39	39	39	34	29	24	19	15	10
Operating Lease Liability Current	14	14	14	14	14	14	15	15	15	16	15	14
Convertible Debt Current	-	-	0	0	575	574	573	572	-	-	0	-
Accounts Payable Trade Current	83	88	96	92	93	91	83	78	107	94	92	94
Contract With Customer Liability Current	12	12	11	11	11	11	10	10	10	8	9	8
Taxes Payable Current	3	3	4	-	-	-	0	-	-	-	-	-
Employee Related Liabilities Current	68	58	74	75	67	52	86	76	70	53	75	64
Accrued Liabilities Current	108	133	130	133	131	137	122	132	102	112	101	90
Liabilities Current	331	347	456	364	930	918	922	913	328	302	307	356
Convertible Debt Noncurrent	-	-	-	-	-	-	0	0	572	571	570	570
Secured Long Term Debt	1,736	1,750	1,730	1,709	1,118	1,129	1,088	1,132	1,152	1,171	826	850
Operating Lease Liability Noncurrent	163	160	163	161	159	161	167	168	170	170	167	168
Deferred Income Tax Liabilities Net	3	6	6	58	60	58	61	69	87	31	35	74
Other Liabilities Noncurrent	194	196	204	233	253	160	146	190	155	140	200	142
Liabilities	2,520	2,535	2,559	2,609	2,629	2,529	2,492	2,544	2,540	2,480	2,194	2,160
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital Common Stock	1,346	1,341	1,338	1,334	1,328	1,323	1,323	1,317	1,302	1,311	1,302	1,262
Treasury Stock Common Value	-687	-687	-689	-690	-690	-690	-691	-692	-681	-646	-647	-613
Accumulated Other Comprehensive Income Loss Net Of…	-40	-31	-30	-32	-31	-24	-28	-25	-19	-11	-15	2
Retained Earnings Accumulated Deficit	423	419	423	425	431	915	940	920	931	944	947	927
Stockholders Equity	1,043	1,042	1,043	1,038	1,039	1,524	1,545	1,522	1,534	1,598	1,588	1,579
Liabilities And Stockholders Equity	3,563	3,578	3,602	3,646	3,668	4,053	4,037	4,066	4,074	4,078	3,782	3,739
Allowance For Doubtful Accounts Receivable Current	7	7	7	6	7	6	7	7	11	5	5	6
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	15	15	15	15	15	15	15	15	15	15	15	15
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	240	240	240	240	240	240	240	240	240	240	240	240
Common Stock Shares Issued	92	92	92	92	92	92	92	92	92	91	91	91
Treasury Stock Common Shares	14	14	14	14	14	14	14	14	14	13	13	12

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	21.33%	41.91%	49.70%	-	-	-	-	-	-	-	-	-
2025	-4.67%	-7.45%	-1.28%	13.09%	7.53%	14.76%	1.95%	7.11%	5.08%	-21.09%	-1.68%	24.45%
2024	33.54%	25.93%	35.83%	-17.11%	-31.55%	-21.83%	1.91%	-7.42%	8.00%	-9.02%	-35.96%	-45.11%
2023	-	-	-	-	-	-	9.62%	20.99%	21.47%	-12.70%	-25.83%	-28.78%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.60	3.38	2.54	3.14	1.23	1.21	1.17	1.20	3.39	4.68	3.45	2.89
Quick Ratio	1.80	1.67	1.25	1.54	0.62	0.61	0.62	0.63	1.82	3.11	1.96	1.49
Working Capital	860.60M	825.17M	703.56M	779.53M	213.02M	188.80M	159.56M	186.96M	783.97M	1.11B	751.06M	671.52M
Leverage & Debt
Debt to Equity	2.42	2.43	2.45	2.51	2.53	1.66	1.61	1.67	1.66	1.55	1.38	1.37
Interest Coverage TTM	0.71	-5.19	-5.72	-5.89	-6.40	0.12	0.40	0.44	1.08	1.50	2.17	2.84
Debt Ratio	0.71	0.71	0.71	0.72	0.72	0.62	0.62	0.63	0.62	0.61	0.58	0.58
Efficiency & Turnover
Asset Turnover TTM	0.46	0.43	0.43	0.43	0.42	0.40	0.41	0.40	0.40	0.39	0.40	0.41
Days Sales Outstanding TTM	61.11	57.36	61.52	56.70	62.53	55.45	60.25	58.84	61.72	59.07	61.89	59.69
Receivables Turnover TTM	5.97	6.36	5.93	6.44	5.84	6.58	6.06	6.20	5.91	6.18	5.90	6.11
Per Share Metrics
Diluted EPS TTM	-0.09	-6.44	-6.74	-6.45	-6.53	-0.38	-0.09	-0.09	0.31	0.52	0.84	1.26
Free Cash Flow Per Share TTM	0.33	0.05	-0.40	-0.06	-0.49	-0.20	0.32	0.50	0.76	0.78	0.91	1.38
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	52.47%	51.94%	50.86%	52.33%	52.60%	53.54%	54.77%	54.92%	56.02%	56.14%	57.39%	58.88%
Operating Profit Margin TTM	3.98%	-28.36%	-30.17%	-29.26%	-30.87%	0.55%	1.76%	1.84%	4.06%	5.17%	7.23%	9.29%
Net Profit Margin TTM	-0.44%	-30.15%	-31.58%	-30.15%	-30.87%	-1.78%	-0.43%	-0.42%	1.51%	2.63%	4.39%	6.54%
Growth Metrics
Net Revenue Growth (1Y)	1.60%	1.24%	1.53%	4.99%	3.53%	6.19%	4.47%	1.45%	1.37%	-2.07%	-1.03%	-1.44%
Net Income Growth (1Y)	-98.55%	1,612.25%	7,337.70%	7,469.32%	-2,217.00%	-171.97%	-110.25%	-106.49%	-81.99%	-76.59%	-62.48%	-41.70%
EPS Growth (1Y)	-98.56%	1,601.39%	7,370.49%	7,439.24%	-2,236.70%	-173.17%	-110.66%	-106.76%	-81.16%	-75.35%	-61.12%	-39.25%
Valuation Metrics
P/E TTM	-191.66	-1.46	-1.84	-2.22	-1.88	-58.07	-251.52	-212.26	95.39	68.49	51.49	30.18
P/B TTM	1.33	0.70	0.91	1.06	0.91	1.10	1.13	0.91	1.47	1.72	2.20	1.93
P/S TTM	0.84	0.44	0.58	0.67	0.58	1.04	1.08	0.89	1.44	1.80	2.26	1.97
Market Cap	1.39B	724.88M	952.27M	1.10B	941.05M	1.68B	1.75B	1.39B	2.26B	2.76B	3.49B	3.04B
Enterprise Value	2.95B	2.28B	2.49B	2.62B	2.45B	3.18B	3.20B	2.91B	3.79B	3.93B	4.62B	4.20B
Calculated Values
Free Cash Flow TTM	25.80M	4.08M	-31.05M	-4.51M	-37.43M	-15.50M	24.96M	38.04M	58.89M	60.93M	73.09M	109.75M
Net Debt	1.57B	1.55B	1.53B	1.52B	1.51B	1.50B	1.45B	1.52B	1.53B	1.17B	1.13B	1.16B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-05Purchase

Owner: Graves, Jeffrey A

Title: -

Shares: 9,000

Price/Share: $11.35

Value: $102,150.00

Shares Owned: 41,086

Relationship: Director

Ownership: Direct

2024-12-03Sale

Owner: Schwartz, Eric

Title: EVP, Chief Legal Officer & Sec

Shares: 4,070

Price/Share: $24.60

Value: $100,122.00

Shares Owned: 59,511

Relationship: Officer

Ownership: Direct

2024-12-02Sale

Owner: Mcbreen, Michael J.

Title: EVP & President, CSS

Shares: 1,700

Price/Share: $24.16

Value: $41,072.00

Shares Owned: 56,182

Relationship: Officer

Ownership: Direct

2024-08-19Sale

Owner: Mosebrook, Jeffrey

Title: SVP, Fin & Princ Acct Officer

Shares: 1,191

Price/Share: $21.58

Value: $25,701.78

Shares Owned: 36,088

Relationship: Officer

Ownership: Direct

2024-05-23Purchase

Owner: Essig, Stuart

Title: Exec. Chairman of the Board

Shares: 52,641

Price/Share: $28.49

Value: $1,499,742.09

Shares Owned: 487,922

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-05	Graves, Jeffrey A	Director	-	Direct	Purchase	9,000	11.35	$102,150.00	41,086	4
2024-12-03	Schwartz, Eric	Officer	EVP, Chief Legal Officer & Sec	Direct	Sale	4,070	24.60	$100,122.00	59,511	4
2024-12-02	Mcbreen, Michael J.	Officer	EVP & President, CSS	Direct	Sale	1,700	24.16	$41,072.00	56,182	4
2024-08-19	Mosebrook, Jeffrey	Officer	SVP, Fin & Princ Acct Officer	Direct	Sale	1,191	21.58	$25,701.78	36,088	4
2024-05-23	Essig, Stuart	Director,Officer	Exec. Chairman of the Board	Direct	Purchase	52,641	28.49	$1,499,742.09	487,922	4
2024-05-21	Hill, Barbara B	Director	-	Indirect	Purchase	36,350	27.40	$995,990.00	36,350	4
2024-03-06	Davis, Robert T. Jr.	Officer	EVP & President, TT	Direct	Sale	8,348	36.59	$305,453.32	49,893	4
2023-08-09	Mosebrook, Jeffrey	Officer	SVP, Fin & PAO	Direct	Sale	1,177	44.46	$52,329.42	23,458	4
2023-06-01	Schwartz, Eric	Officer	EVP, Chief Legal Officer & Sec	Direct	Purchase	2,640	37.89	$100,029.60	48,597	4
2023-06-01	De, Witte Jan	Director,Officer	President & CEO	Direct	Purchase	7,792	38.50	$299,992.00	12,798	4
2023-03-07	Mcbreen, Michael J.	Officer	EVP & President, CSS	Direct	Sale	1,843	54.29	$100,056.47	28,796	4
2023-03-01	Davis, Robert T. Jr.	Officer	EVP & President, TT	Direct	Sale	1,566	55.21	$86,458.86	45,920	4
2023-02-27	Evoli, Lisa	Officer	EVP & CHRO	Direct	Sale	3,767	57.00	$214,719.00	18,605	4
2022-12-08	Mosebrook, Jeffrey	Officer	SVP, Fin & Princ Acct Officer	Direct	Sale	279	56.22	$15,685.38	8,552	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

95.71%

Inst. Shares: 73,646,734

Shares Outstanding: 76,951,000

2025-12-31

94.83%

Inst. Shares: 72,710,755

Shares Outstanding: 76,672,000

2025-09-30

94.13%

Inst. Shares: 72,248,462

Shares Outstanding: 76,753,000

2025-06-30

93.79%

Inst. Shares: 71,929,202

Shares Outstanding: 76,695,000

2025-03-31

92.84%

Inst. Shares: 70,990,349

Shares Outstanding: 76,463,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	73,646,734	76,951,000	95.71%
2025-12-31	72,710,755	76,672,000	94.83%
2025-09-30	72,248,462	76,753,000	94.13%
2025-06-30	71,929,202	76,695,000	93.79%
2025-03-31	70,990,349	76,463,000	92.84%
2024-12-31	66,470,661	77,010,000	86.31%
2024-09-30	66,202,848	76,448,000	86.60%
2024-06-30	68,377,658	77,409,000	88.33%
2024-03-31	63,268,884	77,735,000	81.39%
2023-12-31	64,543,821	80,089,000	80.59%
2023-09-30	65,586,081	79,690,000	82.30%
2023-06-30	65,172,366	80,966,000	80.49%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) — SEC Financial Statements & Analysis

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) is a surgical & medical instruments & apparatus company, incorporated in DE. INTEGRA LIFESCIENCES HOLDINGS CORP trades on Nasdaq as: IART. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), INTEGRA LIFESCIENCES HOLDINGS CORP reported a 1.60% year-over-year revenue growth, a Gross Profit Margin of 52.47% (TTM), a Debt-to-Equity ratio of 2.42x, a Price-to-Sales (P/S) ratio of 0.84x (TTM), a Price-to-Book (P/B) ratio of 1.33x (TTM), at a market cap of $1.39B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 1.60%
Gross Profit Margin TTM: 52.47%
Debt To Equity: 2.42x
P/S TTM: 0.84x
P/B TTM: 1.33x
Market Cap: $1.39B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is INTEGRA LIFESCIENCES HOLDINGS CORP in?

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) operates in the Surgical & Medical Instruments & Apparatus industry.

What is IART's market cap?

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) has a market capitalization of $1.39B as of 2026-06-30.

What exchange does IART trade on?

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) trades on the Nasdaq.

Where is INTEGRA LIFESCIENCES HOLDINGS CORP incorporated?

INTEGRA LIFESCIENCES HOLDINGS CORP is incorporated in DE.